Hans Vidar Wendel-Hansen

Board of Directors, VWH & Company Aktiebolag

Gullvivevägen 6SE3 active roles

Hans Vidar Wendel-Hansen is a Swedish director with 3 active roles across Swedish companies, including Board of Directors at VWH & Company Aktiebolag.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

in directorship history

Career timeline

2022 – now
Board of Directors, VWH & Company Aktiebolag
2022 – now
Chief Executive Officer, SeqCure Immunology AB
2022 – 2025
Chief Executive Officer, Tanea Medical AB
2022 – 2024
Chief Executive Officer, Sista versen 89166 AB
2020 – now
Board of Directors, Castello di Vaglio Serra AB
2020 – 2025
Board of Directors, QuiaPEG Pharmaceuticals AB
2020 – 2024
Board of Directors, QUIA PHARMA AB (publ)
2020 – 2020
Board of Directors, Asarina Pharma AB (publ)

Personal details

Nationality

Address

Gullvivevägen 6

Hans Vidar Wendel-Hansen

Overview

Career timeline

Personal details

More on Hans Vidar Wendel-Hansen

Overview

Career timeline

Personal details

More on Hans Vidar Wendel-Hansen